In our study, it was found that ERBB2 is the low expression in cutaneous melanoma tissues, but this expression may not affect tumor stage and disease-free survival; however, it is related to the 5 years survival rates of cutaneous melanoma patients. Here, ERBB2 is linked to cutaneous melanoma.